CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and ...

Colossal, a genetics startup, has birthed three pups that contain ancient DNA retrieved from the remains of the animal’s ...

Ernexa's core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into ... in their entirety by these cautionary statements. For a detailed description of ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.

the scientists found a way to turn regular body cells into special stem cells, called induced pluripotent stem (iPS) cells, which can change into different types of cells. They took iPS cells from a ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Researchers have performed the first known ...

His parents enrolled him in a study that was collecting and storing immature testicular tissue, and the sperm-forming stem cells in them, from young patients with the goal of eventually giving ...